Pressido 200 200 mg Metered Dose Inhaler
PDF Leaflet Revision Date: 24 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of asthma symptoms.
Dosage (summary)
Initial: 400 u03bcg daily; max: 1600 u03bcg.
Onset of Action / Duration
Onset: 20 mins, Duration: Not specified
Special Populations
- Paediatric population
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy and lactation.
Key Drug Interactions
- CYP3A4 inhibitors
- Itraconazole
- Ketoconazole
Contraindications
- Hypersensitivity to budesonide
- Active pulmonary tuberculosis
- Untreated airway infections
Common side effects
- Oropharyngeal candidiasis
- Paradoxical bronchospasm
- Cough
- Hoarseness
Counselling Points
- Rinse mouth after use
- Do not stop abruptly
- Use bronchodilators before inhalation
Serious warnings
- Adrenal suppression
- Pneumonia in COPD patients
- Visual disturbances
Important Disclaimer
The Pressido 200 200 mg Metered Dose Inhaler professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
